Autori: Longo A

Filtra

Data

Body mass index in type 2 spinal muscular atrophy: a longitudinal study

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies

Torna in alto